Breaking News Instant updates and real-time market news.

BIIB

Biogen

$318.11

-0.21 (-0.07%)

09:10
11/23/16
11/23
09:10
11/23/16
09:10

Morgan Stanley expects big reversal today in Biogen shares

Morgan Stanley Matthew Harrison expects shares of Biogen (BIIB) to end the trading day flat or slightly higher. The stock is currently down $26.61, or 8%, to $291.50 in pre-market trading. With Biogen's aducanumab more potent than Eli Lilly's solanezumab, the Alzheimer's drug still has potential for success, Harrison tells investors in a research note. He points out that Lilly management noted that "the study results, including many secondary clinical endpoints, directionally favored solanezumab." Harrison sees hope in the amyloid hypothesis. The analyst has an Overweight rating on Biogen.

  • 29

    Nov

BIIB Biogen
$318.11

-0.21 (-0.07%)

11/09/16
RBCM
11/09/16
NO CHANGE
RBCM
Biotech stocks should be bought on post-election decline, says RBC Capital
RBC Capital recommends buying biotech stocks today on weakness. The firm notes that stocks usually rebound after they drop due to political events that don't affect their fundamentals, and it believes that the decline in biotech stocks today is in that category. The firm says that President-elect Trump probably won't focus on drug prices or Medicare reform. It adds that biotech companies should benefit from the fact that Congress will stay in GOP hands and the apparent failure of California's Proposition 61 initiative. The firm identifies Celgene (CELG), Biogen (BIIB), Vertex (VRTX), BioMarin (BMRN), and Prothena (PRTA) as its favorite names in the sector.
11/09/16
PIPR
11/09/16
NO CHANGE
PIPR
Piper sees improving environment for Biopharma M&A
The biotech sector is seeing a "massive relief rally" given the "surprise trifecta" of a Republican sweep, the voting down of Prop 61 in California and U.S. dollar weakness, Piper Jaffray analyst Joshua Schimmer tells investors in a research note. The door is now open to discuss potential repatriation of cash outside the U.S., which could be a green light on mergers and acquisitions, the analyst adds. He points out that Amgen (AMGN) and Gilead (GILD) hold the most overseas cash, with Celgene (CELG) and Biogen (BIIB) holding several billion as well. Schimmer believes the broader environment may be improving for M&A. He cautions, though, that the election of Trump does not remove the "major drug pricing overhang question."
11/23/16
SBSH
11/23/16
NO CHANGE
Target $305
SBSH
Neutral
Citi pegs potential Biogen downside to $287 on Lilly failure
In a research note dated yesterday, Citi analyst Robyn Karnauskas said shares of Biogen (BIIB) could fall to $286 should Eli Lilly's (LLY) Alzheimer's drug solanezumab fail in its Phase 3 study. After Lilly reported this morning that the trial failed, shares of Biogen are down 6%, or $18.60, to $299.51 in pre-market trading. Shares of Lilly are down 14%, or $10.77, to $65.22. Karnauskas estimated the downside range of Biogen on a failed solanezumab study at $287-$306. The analyst has a Neutral rating on Biogen.
11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Overweight
Piper's Schimmer proclaims amyloid hypothesis is not dead
Piper Jaffray analyst Joshua Schimmer says the failure of Eli Lilly's (LLY) solanezumab is not the final nail in the amyloid hypothesis coffin. Biogen (BIIB) and Eisai's aducanimab study is the most potent approach for amyloid lowering, Schimmer tells investors in a research note. He points out that he was skeptical whether solanezumab's effect was adequate. "Our view of Alzheimer's for amyloid is informed not so much by the extremely sloppy science in that disease, but by consistent cause/effect signals across other amyloidosis," Schimmer writes. He believes today's selloff in shares of Biogen "creates some breathing room." The analyst recommends looking to build a position in Biogen after the stock settles down. Schimmer reiterates an Overweight rating on the shares with a $335 price target. The stock is down 8%, or $24.41, to $293.70 in pre-market trading.

TODAY'S FREE FLY STORIES

ICHR

Ichor Holdings

$25.60

0.86 (3.48%)

13:18
01/17/18
01/17
13:18
01/17/18
13:18
Recommendations
Ichor Holdings analyst commentary  »

Ichor Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 07

    Feb

IPSEY

Ipsen

13:18
01/17/18
01/17
13:18
01/17/18
13:18
Hot Stocks
Ipsen: Onivyde+-FU/LV improved overall survival in Phase 3 study »

Ipsen Biopharmaceuticals,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

$NSD

NASDAQ Market Internals

13:17
01/17/18
01/17
13:17
01/17/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
01/17/18
01/17
13:16
01/17/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$63.42

0.92 (1.47%)

13:15
01/17/18
01/17
13:15
01/17/18
13:15
Hot Stocks
Wells Fargo announces retirement of chief risk officer Mike Loughlin »

Wells Fargo & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACLS

Axcelis

$30.30

1.15 (3.95%)

, AMAT

Applied Materials

$54.50

1.05 (1.96%)

13:14
01/17/18
01/17
13:14
01/17/18
13:14
Recommendations
Axcelis, Applied Materials analyst commentary  »

Axcelis presentation an…

ACLS

Axcelis

$30.30

1.15 (3.95%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

AVGO

Broadcom

$263.25

-1.04 (-0.39%)

13:12
01/17/18
01/17
13:12
01/17/18
13:12
Periodicals
Broadcom probed by FTC over negotiations with customers, WSJ reports »

The FTC is probing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLM

Sallie Mae

$11.47

-0.24 (-2.05%)

13:08
01/17/18
01/17
13:08
01/17/18
13:08
Technical Analysis
Technical Earnings Preview: SLM Corp in middle of range before news »

Shares have been trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:08
01/17/18
01/17
13:08
01/17/18
13:08
Hot Stocks
Apple announces new U.S. investments, sees $38B of repatriation taxes »

Apple announced a new set…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

13:05
01/17/18
01/17
13:05
01/17/18
13:05
General news
Treasury Action: early March bills continue to underperform »

Treasury Action: early…

FOX

21st Century Fox

$35.79

-0.58 (-1.59%)

, FOXA

21st Century Fox

$36.29

-0.44 (-1.20%)

13:04
01/17/18
01/17
13:04
01/17/18
13:04
Periodicals
FoxNext acquires game developer Cold Iron Studios, Polygon says »

FoxNext Games, the video…

FOX

21st Century Fox

$35.79

-0.58 (-1.59%)

FOXA

21st Century Fox

$36.29

-0.44 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 07

    Feb

  • 07

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:02
01/17/18
01/17
13:02
01/17/18
13:02
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple breaking ground…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:01
01/17/18
01/17
13:01
01/17/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple sees investing over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

AAPL

Apple

$176.19

-0.9 (-0.51%)

13:01
01/17/18
01/17
13:01
01/17/18
13:01
Hot Stocks
Breaking Hot Stocks news story on Apple »

Apple announces new set…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

UPS

UPS

$133.62

0.74 (0.56%)

13:00
01/17/18
01/17
13:00
01/17/18
13:00
Options
Notable call spread in UPS as shares deliver profits »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AA

Alcoa

$56.35

0.11 (0.20%)

12:57
01/17/18
01/17
12:57
01/17/18
12:57
Technical Analysis
Technical Earnings Preview: Alcoa near 52-week high before news »

Ahead of earnings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

AAPL

Apple

$176.19

-0.9 (-0.51%)

, BMWYY

BMW

$37.64

1.125 (3.08%)

12:51
01/17/18
01/17
12:51
01/17/18
12:51
Periodicals
BMW to offer CarPlay as subscription-based service next year, The Verge says »

BMW (BMWYY) plans to…

AAPL

Apple

$176.19

-0.9 (-0.51%)

BMWYY

BMW

$37.64

1.125 (3.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

TBT

ProShares UltraShort 20+ yr Trsry

$34.72

-0.06 (-0.17%)

12:50
01/17/18
01/17
12:50
01/17/18
12:50
Options
Closing puts in the ProShares UltraShort Longer-term Bond ETF »

Closing puts in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:50
01/17/18
01/17
12:50
01/17/18
12:50
General news
U.S. equities extended their bounce »

U.S. equities extended…

ERJ

Embraer

$24.67

-0.1125 (-0.45%)

, BA

Boeing

$347.06

11.9016 (3.55%)

12:48
01/17/18
01/17
12:48
01/17/18
12:48
Periodicals
Embraer tells Bloomberg no guarantee Boeing talks with result in deal »

Embraer (ERJ), in an…

ERJ

Embraer

$24.67

-0.1125 (-0.45%)

BA

Boeing

$347.06

11.9016 (3.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

ASML

ASML

$186.38

5.51 (3.05%)

, LRCX

Lam Research

$190.39

1.88 (1.00%)

12:46
01/17/18
01/17
12:46
01/17/18
12:46
Hot Stocks
ASML results pull semiconductor equipment maker shares higher »

Shares of semiconductor…

ASML

ASML

$186.38

5.51 (3.05%)

LRCX

Lam Research

$190.39

1.88 (1.00%)

KLAC

KLA-Tencor

$107.66

0.37 (0.34%)

AMAT

Applied Materials

$54.50

1.05 (1.96%)

TER

Teradyne

$46.51

1.2 (2.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

BCS

Barclays

$11.01

0.045 (0.41%)

12:45
01/17/18
01/17
12:45
01/17/18
12:45
Periodicals
Barclays slashes up to 100 senior investment bank staff, Bloomberg says »

Barclays is cutting up to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

12:41
01/17/18
01/17
12:41
01/17/18
12:41
Technical Analysis
Technical Earnings Preview: Kinder Morgan in uptrend before results »

The stock has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

FB

Facebook

$178.39

-0.98 (-0.55%)

12:41
01/17/18
01/17
12:41
01/17/18
12:41
Hot Stocks
Facebook initiates new probe into possible Russian meddling around Brexit vote »

Facebook's U.K.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

PSX

Phillips 66

$106.20

2.7 (2.61%)

12:40
01/17/18
01/17
12:40
01/17/18
12:40
Options
Notable call buying in Phillips 66 as shares see relative strength »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.